Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Uveitis Steroid Treatment Trial
2007-003612-53Phase 3Completed
- Sponsor
- National Institutes of Health
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of fluocinolone in noninfectious uveitis (NIU) (2 arms), sponsored by National Institutes of Health. Primary endpoint: Change in best-corrected visual acuity. Started Jan 2008; status: completed.
02
Drugs
fluocinolone
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on 2007-003612-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003612-53.